A Case of Recurrent Chalazia Associated with Subclinical Hypothyroidism.

Autor: Bipat R; Department of Physiology, Faculty of Medical Science, Anton de Kom University of Suriname, Paramaribo, Suriname., Jiawan D; Departments of Ophthalmology, Academic Hospital Suriname and Faculty of Medical Science, Anton de Kom University of Suriname, Paramaribo, Suriname., Toelsie JR; Department of Physiology, Faculty of Medical Science, Anton de Kom University of Suriname, Paramaribo, Suriname.
Jazyk: angličtina
Zdroj: Case reports in ophthalmology [Case Rep Ophthalmol] 2020 Jun 09; Vol. 11 (2), pp. 212-216. Date of Electronic Publication: 2020 Jun 09 (Print Publication: 2020).
DOI: 10.1159/000508603
Abstrakt: Chalazia are chronic inflammatory disorders of the Meibomian glands of the eyelids that can present at any age. Although the exact cause is still obscure, they are often associated with retention of lipids in these sebaceous glands, infections, or disturbances in the balance of sex hormones. The complications of the disease may vary from little discomfort to reduced vision. Treatment strategies include hot compresses, intralesional steroid injections, and incision and curettage. The present case is about a female in her forties with a 4-year long history of recurrent chalazia. The management of the majority of the lesions was through incision and curettage. Concomitantly she presented with subclinical hypothyroidism, for which she received treatment. During treatment of the hypothyroidism, there was a remission of the chalazia. After cessation of the treatment with levothyroxine, the chalazia started recurring. Reinstatement of a low-dose treatment with levothyroxine eventually led to a remission and prevented further recurrence of the chalazia. Subclinical hypothyroidism may predispose to recurrent chalazia. This finding may have consequences for the understanding of the pathophysiology and the management of this disorder. Further investigations must elicit the exact mechanism of this association.
Competing Interests: The authors have no conflicts of interest to declare.
(Copyright © 2020 by S. Karger AG, Basel.)
Databáze: MEDLINE